Global clinical response in Cushing's syndrome patients treated with mifepristone

Improvement in Insulin Sensitivity During Mifepristone Treatment of Cushing Syndrome:Early and Late Effects

(2013) Amisha Wallia et al.   DIABETES CARE

Medical Treatment of Cushing's Disease

(2013) Richard A. Feelders et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

New developments in the medical treatment of Cushing's syndrome

(2012) R van der Pas et al.   ENDOCRINE-RELATED CANCER

Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome

(2012) Maria Fleseriu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease

(2012) Annamaria Colao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Medical management of Cushing’s disease: what is the future?

(2012) Maria Fleseriu et al.   Pituitary

Assessing Inter-Rater Reliability (IRR) of Tanner Staging and Orchidometer Use with Boys: A Study from PROS

(2011) E.J. Slora et al.   JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Age and gender differences in seven tests of functional mobility

(2009) Annie A Butler et al.   Journal of NeuroEngineering and Rehabilitation

Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease

(2008) F Castinetti et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY